UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal

Journal of clinical pharmacology, 2024-06, Vol.64 (6), p.652-671

2024

Volltextzugriff (PDF)

Backpedaling on Baclofen: Highlighting Concerns Surrounding Baclofen Use in Phenibut Withdrawal: Letter to the Editor Response

Journal of clinical pharmacology, 2024-06

2024

Volltextzugriff (PDF)

Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)

Journal of clinical pharmacology, 2022-05, Vol.62 (5), p.577-593

2022

Volltextzugriff (PDF)

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

Nature (London), 2014-10, Vol.514 (7524), p.642-645

2014

Volltextzugriff (PDF)

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

CNS drugs, 2018-03, Vol.32 (3), p.241-257

2018

Volltextzugriff (PDF)

4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation

Journal of clinical pharmacology, 2019-05, Vol.59 (5), p.611-624

2019

Volltextzugriff (PDF)

Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability

International journal of nanomedicine, 2016-01, Vol.11, p.1451-1460

2016

Volltextzugriff (PDF)

Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach

Therapeutic drug monitoring, 2023-08, Vol.45 (4), p.539

2023

Volltextzugriff (PDF)

Adverse interactions between antifungal azoles and vincristine: review and analysis of cases

Mycoses, 2012-07, Vol.55 (4), p.290-297

2012

Volltextzugriff (PDF)

Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) Activity in Healthy Participants

Journal of clinical pharmacology, 2012-06, Vol.52 (6), p.932-939

2012

Volltextzugriff (PDF)

Pharmacokinetic Drug Interactions with Panax ginseng

European journal of drug metabolism and pharmacokinetics, 2017-08, Vol.42 (4), p.545-557

2017

Volltextzugriff (PDF)

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Volltextzugriff (PDF)

Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis

Clinical journal of the American Society of Nephrology, 2007-09, Vol.2 (5), p.906-913

2007

Volltextzugriff (PDF)

Response to “Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A422 to Metabolism of Voriconazole”

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.187-187

2018

Volltextzugriff (PDF)

Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults

International journal of clinical pharmacology and therapeutics, 2023-06, Vol.61 (6), p.262

2023

Volltextzugriff (PDF)

Knowledge of Kratom among Alabama Pharmacists

Pharmacy, 2023-12, Vol.12 (1), p.6

2023

Volltextzugriff (PDF)

Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

CNS drugs, 2018-06, Vol.32 (6), p.603-603

2018

Volltextzugriff (PDF)

Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition

The New England journal of medicine, 2006-08, Vol.355 (6), p.581-592

2006

Volltextzugriff (PDF)

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome

Blood, 2011-11, Vol.118 (18), p.4957-4962

2011

Volltextzugriff (PDF)

Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates

PloS one, 2014-12, Vol.9 (12), p.e115506-e115506

2014

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Oral Posaconazole in Neutropenic Stem Cell Transplant Recipients

Antimicrobial Agents and Chemotherapy, 2006-06, Vol.50 (6), p.1993-1999

2006

Volltextzugriff (PDF)

Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV

AIDS (London), 2011-03, Vol.25 (6), p.787-795

2011

Volltextzugriff (PDF)

HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo

PloS one, 2014-07, Vol.9 (7), p.e100138

2014

Volltextzugriff (PDF)

Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers

Circulation (New York, N.Y.), 2016-12, Vol.134 (23), p.1909-1911

2016

Volltextzugriff (PDF)

Integrating pharmacogenetic information and clinical decision support into the electronic health record

Journal of the American Medical Informatics Association : JAMIA, 2014-05, Vol.21 (3), p.522-528

2014

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(125)
Buchkapitel
(33)
Bücher
(2)
Berichte
(2)

Sprache

Englisch
(162)
Japanisch
(11)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(94)
Humans
(79)
Pharmacology & Pharmacy
(62)
Male
(53)
Female
(43)
Adult
(41)
Biological And Medical Sciences
(41)
Medical Sciences
(41)
Pharmacology. Drug Treatments
(29)
Drug Interactions
(27)
Pharmacokinetics
(27)
Pharmacology
(24)
Hiv
(23)
Infectious Diseases
(23)
Middle Aged
(23)
Human Immunodeficiency Virus
(20)
Cytochrome P450
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(15)
Hiv Infections - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal

Backpedaling on Baclofen: Highlighting Concerns Surrounding Baclofen Use in Phenibut Withdrawal: Letter to the Editor Response

Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation

Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability

Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach

Adverse interactions between antifungal azoles and vincristine: review and analysis of cases

Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) Activity in Healthy Participants

Pharmacokinetic Drug Interactions with Panax ginseng

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran

Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis

Response to “Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A422 to Metabolism of Voriconazole”

Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults

Knowledge of Kratom among Alabama Pharmacists

Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome

Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates

Pharmacokinetics and Safety of Oral Posaconazole in Neutropenic Stem Cell Transplant Recipients

Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV

HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo

Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers

Integrating pharmacogenetic information and clinical decision support into the electronic health record

Suchergebnisse filtern